SCIENSUS LOGISTICS LIMITED

Active Burton-On-Trent
250 employees website.com
Life sciences and medical technology
S

SCIENSUS LOGISTICS LIMITED

Founded 20 May 2021 Active Burton-On-Trent, England 250 employees website.com
Life sciences and medical technology

Previous Company Names

SCIENSUS CLINICAL LIMITED 20 May 2021 — 15 Dec 2023
Accounts Due 30 Sept 2026 3 months remaining
Confirmation Submitted 1 Jun 2026 Next due 22 May 2027 11 months remaining
Net assets £164K £164K 2024 year on year
Total assets £656K £656K 2024 year on year
Total Liabilities £492K
Charges 1
1 outstanding

Contact & Details

Contact

Registered Address

107 Station Street Burton-On-Trent DE14 1SZ England

Telephone

0800 000 0000

Website

www.example.com

Full company profile for SCIENSUS LOGISTICS LIMITED (13412146), an active life sciences and medical technology company based in Burton-On-Trent, England. Incorporated 20 May 2021. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Apr → 31 Mar 2025
Type full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Balance Sheet & P&L (2022–2024)

Cash in Bank

£656.00k

Net Assets

£164.00k

Increased by £164.00k (+16399900%)

Total Liabilities

£492.00k

Turnover

£20.30M

Employees

250

Debt Ratio

75%

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Mar Year End
2024
31 Mar Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Francesca GerettoDirectorItalianEngland4914 Nov 2024Active

Shareholders

Shareholders (1)

Sciensus Pharma Services Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 20 May 2021
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

SCIENSUS LOGISTICS LIMITED Current Company

Charges

Charges

1 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
4 Jun 2026OfficersTermination of Annabelle Newman as director on 3 Jun 2026
1 Jun 2026Confirmation StatementConfirmation statement made on 8 May 2026 with no updates
29 May 2026Confirmation StatementConfirmation statement made on 11 May 2026 with no updates
29 May 2026OfficersTermination of Christian Tucat as director on 8 May 2026
27 May 2026OfficersAppointment of Mr Gordon David Cox as director on 8 May 2026
4 Jun 2026 Officers

Termination of Annabelle Newman as director on 3 Jun 2026

1 Jun 2026 Confirmation Statement

Confirmation statement made on 8 May 2026 with no updates

29 May 2026 Confirmation Statement

Confirmation statement made on 11 May 2026 with no updates

29 May 2026 Officers

Termination of Christian Tucat as director on 8 May 2026

27 May 2026 Officers

Appointment of Mr Gordon David Cox as director on 8 May 2026

Recent Activity

Latest Activity

Termination of Annabelle Newman as director on 3 Jun 2026

5 days ago on 4 Jun 2026

Confirmation statement made on 8 May 2026 with no updates

1 weeks ago on 1 Jun 2026

Confirmation statement made on 11 May 2026 with no updates

1 weeks ago on 29 May 2026

Termination of Christian Tucat as director on 8 May 2026

1 weeks ago on 29 May 2026

Appointment of Mr Gordon David Cox as director on 8 May 2026

1 weeks ago on 27 May 2026